Cookies

Our website uses cookies and other similar tools. We also analyze anonymized web traffic. You can choose your cookie preferences below. You may choose only necessary cookies, specific cookies or all cookies. Read more in our privacy policy

Medaffcon - interactive tools - interaktiiviset työkalut

Home > Interactive value tools

Interactive value tools

Interactive value tools combine published research data, local patient- and sales data and health economic analysis into one easy-to-use tool.

Contact us!

Medaffcon’s interactive value tools combine published research data, local patient- and sales data and health economic analysis into one easy-to-use tool. All relevant data is presented in an understandable and practical manner. The data can be further extended with Medaffcon’s RWE studies and Fast Track data requests or the tool can be specifically tailored to present these results.

The aim is to provide a visually pleasant, interactive user experience and data formability according to user needs.

Medaffcon - Interactive value tools for customer interface

Interactive tools for the customer interface

Interactive tools are especially popular in the customer interface where they can be used to support and adapt campaigns and research publications. The tools enable i.e.:

  • assessment of local patient population
  • assessment of local treatment costs
  • assessment of local budget impact
  • assessment of benefits or harms of treatment in desired areas
  • comparisons between different treatment options
Interactive value tools combine large data entities

Medaffcon’s multifunctional team executes interactive tools for the needs of sales, marketing, medical and market access departments. Depending on the scope of the project, we utilize our extensive medical, health economic and data-analysis expertise.

Interactive tools are most commonly built using software such as Microsoft Excel or PowerBI but are also possible to implement using other alternatives.

Watch a video introduction

Related articles

Mariann Lassenius

Mariann Lassenius

Sr. Scientific Advisor

RWE Lead

PhD

+358 50 345 2393

Mariann joined Medaffcon’s team in 2016 after finishing her PhD. The transition to real world evidence (RWE) research was a natural continuum to her previous research career. Through RWE studies, she has had the privilege to gain a broad insight into working with different stakeholders within the healthcare field. The vast proportion of her days goes towards interacting with clients, planning and performing RWE studies, and supporting Medaffcon’s RWE team. Subjects that keep her work interesting are the vast variability of customers and projects, problem-solving, and interacting with people.

“The number of RWE studies has increased since stakeholders within the healthcare industry have an increasing demand for knowledge-based decision making tools that need to be fulfilled. The future, therefore, has an ever-increasing emphasis on RWE”.

Simo Jääskeläinen

Simo Jääskeläinen

Market Access Lead

MSc (Health Sciences), BBA

+358 40 580 0567

Simo started as the leader of Medaffcon’s Market Access team in November 2024. He is a returnee, as he has also previously worked at Medaffcon. Before returning to Medaffcon, Simo worked in a pharmaceutical company as the head of a Market Access team and has also gained Market Access experience in other pharmaceutical companies. He has over 20 years of experience in the pharmaceutical industry. Simo holds a Master’s degree in Health Sciences and a Bachelor’s degree in Business Administration.

Simo brings to Medaffcon a strong and versatile background in the pharmaceutical industry, particularly in Market Access roles. His strengths include versatility, organizational skills, and the ability to see the bigger picture. In the field of Market Access, Simo does not consider himself an expert in any particular subfield but sees himself as a generalist. He is drawn to the challenges of the industry and the opportunity to find comprehensive solutions that meet the needs of clients.

Ongoing changes in the operating environment require pharmaceutical companies to adapt and adopt new ways of working. Simo believes that the role and importance of Market Access will become even more prominent in a situation where society’s willingness to pay and the needs of the pharmaceutical industry must be aligned in a way that benefits both parties.

Iiro Toppila

Iiro Toppila

Biostatistician

Data Analysis Lead

MSc (Tech.)

+358 44 314 1597

Iiro joined Medaffcon in March 2017 as a Biostatistician. For the preceding four years, he has worked as a research assistant in an academic study group, analyzing clinical and genetic patient data. Iiro holds a Master of Science degree in Technology in Bioinformation Technology.

Iiro’s strengths include his strong expertise in statistics and data-analysis, hands-on experience in working with sensitive patient data, and strong interdisciplinary communication skills with experts from various fields. In the field, he is particularly interested in the large data amounts made available with the revolution of technology and how the information received such data can potentially be utilized to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment.

“Machine learning and AI-based solutions will have a major impact on the healthcare sector now and in the future. However, effectively utilizing the already collected and available health-data will have a higher importance in order to improve health-care”.